HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) Director Gayle Furgurson Wellborn sold 2,439 shares of the company’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. The trade was a 11.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
HealthEquity Price Performance
Shares of HQY opened at $88.34 on Wednesday. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $116.65. The business has a 50-day simple moving average of $83.63 and a two-hundred day simple moving average of $86.61. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The stock has a market cap of $7.39 billion, a PE ratio of 33.09, a PEG ratio of 1.55 and a beta of 0.21.
HealthEquity (NASDAQ:HQY – Get Free Report) last issued its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. The business’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Analysts anticipate that HealthEquity, Inc. will post 3.84 earnings per share for the current fiscal year.
Institutional Investors Weigh In On HealthEquity
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the company. BTIG Research lowered their target price on HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a report on Tuesday, February 17th. Wells Fargo & Company set a $111.00 price target on HealthEquity in a research note on Monday. Jefferies Financial Group set a $108.00 price target on HealthEquity in a research note on Thursday, February 19th. Barrington Research reissued an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. Finally, Citizens Jmp increased their price target on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and a consensus price target of $111.53.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Featured Stories
- Five stocks we like better than HealthEquity
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
